Wednesday, November 25, 2009, 9:22am SGT - The Singapore stock market closes in 7 hours and 38 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Albany Molecular Research Inc. (AMRI)

At 5:00AM SGT: 8.52 USD  Up 0.17 (2.04%)  
 MORE ON AMRI 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Albany Molecular Research, Inc. (NasdaqNM:AMRI) Delayed quote dataEdit
After Hours: 8.52 Down 0.00 (0.02%) as of 5:15am SGT on 11/25/09
Last Trade:8.52 USD
Trade Time:5:00AM SGT
Change:Up 0.17 (2.04%)
Prev Close:8.35
Open:8.30
Bid:8.30 x 200
Ask:9.41 x 100
1y Target Est:8.00
Day's Range:8.26 - 8.52
52wk Range:7.31 - 12.56
Volume:115,823
Avg Vol (3m):101,186
Market Cap:269.60M
P/E (ttm):47.07
EPS (ttm):0.18
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add AMRI to Portfolio   Download Data

 HEADLINES 
•ALBANY MOLECULAR RESEARCH INC Financials
EDGAR Online Financials (Fri, Nov 13)
•AMRI’s quarterly earnings, revenue down
at bizjournals.com (Mon, Nov 9)
•ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
EDGAR Online (Mon, Nov 9)
•Q3 2009 Albany Molecular Research Earnings Release - Before Market Open
CCBN (Mon, Nov 9)
•AMRI Announces Third Quarter 2009 Results
Business Wire (Mon, Nov 9)
•AMRI receives $750K milestone payment
at bizjournals.com (Tue, Nov 3)
•Third Compound from AMRI Bristol-Myers Squibb Collaboration Selected for Preclinical Development
Business Wire (Mon, Nov 2)
•AMRI to Present at the Oppenheimer 20th Annual Healthcare Conference
Business Wire (Fri, Oct 30)
•AMRI to Announce Third Quarter Results
Business Wire (Mon, Oct 26)
•Daines: Treat flu-like symptoms as H1N1
at bizjournals.com (Fri, Oct 23)
More Headlines for AMRI...
 ANALYST 
EPS Est (next year) (Dec-09) :0.03
EPS Est (in 2 years) (Dec-10) :0.11
Avg Rec (current)*:3.0
PEG Ratio:27.13
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Albany Molecular Research, Inc. provides contract services to various pharmaceutical and biotechnology companies primarily in the United States and Europe.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices